POSC340 Health-Related Quality of Life Among Refractory/Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with KTE-X19: Phase 2 Results from Zuma-3 Trial
Abstract
Authors
BD Shah C Solem C Feng GA Maglinte WJ Wang T Shen BK Masouleh R Houot